Specifically, we observed a significant decrease in the expression of anti-apoptotic genes Bcl-XL and Bcl-2 in lymphoma cells treated with eimbinostat, which may partially account for the observed induction of apoptosis. The gene discussed is BCL2; the disease is lymphoma.